Youre eating slower, feeling full faster
Semaglutide and Tirzepatide: Obesity Medicine Physician FAQs Semaglutide and Tirzepatide: Obesity Medicine Physician FAQs Anti-obesity medications like Semaglutide (Wegovy) and Tirzepatide (Zepbound) have shown significant results for weight loss, with results ranging from 14.9% to 17.4% total body weight loss from baseline in the STEP trials for Semaglutide, and 25.3% total body weight loss from baseline for Tirzepatide in the SURMOUNT-4 trial
For a comprehensive overview of the current regulatory environment, read our are research peptides legal in 2026 guide and our FDA peptide reclassification 2026 update
Purification and physicochemical properties [PMID: 5768856] Laboratory literature summary: hCG
Why We Like the Combination of BPC-157 With GHK-Cu and NAD+ In addition to BPC-157 , PushPatch is a strategic combination of: GHK-Cu (Copper Peptide) supports collagen production and skin regeneration NAD+ impacts so many aspects of health, including supporting cellular energy and resilience Think of it like this: BPC-157 helps signal repair and recovery GHK-Cu supports structural rebuilding (e.g., skin damage from sunburn) NAD+ provides the cellular energy needed for repair and resilience, and many people notice that increases in NAD+ lead to improved energy, focus, and recovery